We are live on ! Find out more
IMPL

Impel Pharmaceuticals Inc. Common Stock

Delisted

IMPL was delisted on the 15th of December, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
KKRC
1
Kohlberg Kravis Roberts & Co
New York
$26.3M
5VM
2
5AM Venture Management
California
$18.4M
VC
3
Vivo Capital
California
$18.4M
VP
4
venBio Partners
California
$17.6M
Vanguard Group
5
Vanguard Group
Pennsylvania
$3.39M +$303K +40,032 +8%
DA
6
DCF Advisers
Connecticut
$2.34M +$839K +111,031 +43%
BlackRock
7
BlackRock
New York
$2.2M -$71.1K -9,405 -3%
LM
8
Lasry Marc
$2.1M
State Street
9
State Street
Massachusetts
$1.15M +$84K +11,107 +7%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$1.03M +$249K +32,989 +26%
BCM
11
Bridgeway Capital Management
Texas
$499K
Northern Trust
12
Northern Trust
Illinois
$318K +$5.01K +663 +1%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$306K -$10.3K -1,361 -3%
Renaissance Technologies
14
Renaissance Technologies
New York
$211K +$251K +33,200 New
Wells Fargo
15
Wells Fargo
California
$178K +$4.86K +643 +2%
Allspring Global Investments
16
Allspring Global Investments
North Carolina
$177K +$9.58K +1,268 +5%
AA
17
ALPS Advisors
Colorado
$151K -$22.6K -2,987 -11%
EP
18
EPIQ Partners
Minnesota
$119K
Bank of America
19
Bank of America
North Carolina
$95K -$16.2K -2,148 -13%
Charles Schwab
20
Charles Schwab
California
$92K +$537 +71 +0.5%
BJL
21
Brighton Jones LLC
Washington
$91K +$529 +70 +0.5%
TFS
22
TrustCore Financial Services
Tennessee
$85K
Goldman Sachs
23
Goldman Sachs
New York
$82K +$16K +2,114 +20%
Qube Research & Technologies (QRT)
24
Qube Research & Technologies (QRT)
United Kingdom
$76K -$64.1K -8,475 -42%
Morgan Stanley
25
Morgan Stanley
New York
$70K -$7.31K -967 -8%